169 related articles for article (PubMed ID: 3282475)
1. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.
Untawale S; Blick M
Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475
[TBL] [Abstract][Full Text] [Related]
2. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman MD; Scott JK; Watt RA; Astrin SM
Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
[TBL] [Abstract][Full Text] [Related]
3. Expression of the myc gene family in different stages of human colorectal cancer.
Finley GG; Schulz NT; Hill SA; Geiser JR; Pipas JM; Meisler AI
Oncogene; 1989 Aug; 4(8):963-71. PubMed ID: 2668847
[TBL] [Abstract][Full Text] [Related]
4. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
5. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
[TBL] [Abstract][Full Text] [Related]
6. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
8. Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53.
Chenevix-Trench G; Martin NG; Ellem KA
Oncogene; 1990 Aug; 5(8):1187-93. PubMed ID: 1697409
[TBL] [Abstract][Full Text] [Related]
9. Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions.
Greco C; Gandolfo GM; Mattei F; Gradilone A; Alvino S; Pastore LI; Casale V; Casole P; Grassi A; Cianciulli AM
Anticancer Res; 1994; 14(3B):1433-40. PubMed ID: 8067719
[TBL] [Abstract][Full Text] [Related]
10. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.
Ramsay RG; Thompson MA; Hayman JA; Reid G; Gonda TJ; Whitehead RH
Cell Growth Differ; 1992 Oct; 3(10):723-30. PubMed ID: 1445802
[TBL] [Abstract][Full Text] [Related]
11. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of the c-myc gene without gene amplification in human lung cancer and colon cancer cell lines.
Yoshimoto K; Hirohashi S; Sekiya T
Jpn J Cancer Res; 1986 Jun; 77(6):540-5. PubMed ID: 3089986
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T
Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095
[TBL] [Abstract][Full Text] [Related]
14. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
16. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
17. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW
Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273
[TBL] [Abstract][Full Text] [Related]
18. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
19. Growth-dependent expression of human Mr 53,000 tumor antigen messenger RNA in normal and neoplastic cells.
Calabretta B; Kaczmarek L; Selleri L; Torelli G; Ming PM; Ming SC; Mercer WE
Cancer Res; 1986 Nov; 46(11):5738-42. PubMed ID: 3019534
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the expression of the oncogene c-myc in human breast adenocarcinoma].
Guérin M; Lacombe MJ; Riou G
C R Acad Sci III; 1985; 301(20):833-8. PubMed ID: 3938309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
